Downloadable Slides

Share

Program Content

Activities

  • BTKi for MCL
    BTK Inhibitors for Mantle Cell Lymphoma: Overview and Current Treatment Landscape
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 05, 2024

    Expires: December 04, 2025

Faculty

cover img faculity

Brad Kahl, MD

Professor of Medicine
Washington University School of Medicine
Director, Lymphoma Program
Siteman Cancer Center
St. Louis, Missouri

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca